You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

 

Online download statistics by month:

Online download statistics by month: June 2021 to April 2023

AbstractFullPdf
Jun 2021371376186
Jul 2021313313124
Aug 2021175175144
Sep 202111711673
Oct 202117317387
Nov 202112212356
Dec 202113213453
Jan 202211312047
Feb 2022758142
Mar 2022697637
Apr 202210410828
May 2022707647
Jun 2022808740
Jul 2022535419
Aug 2022727430
Sep 2022586129
Oct 2022626540
Nov 2022595928
Dec 2022474917
Jan 2023545523
Feb 2023757514
Mar 2023485016
Apr 2023192019
Total246125201199